TrialCancer research and treatment2015

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer.

Seung Tae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.